BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24794953)

  • 1. Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease.
    Barreiro E; Gea J
    Transl Res; 2015 Jan; 165(1):61-73. PubMed ID: 24794953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction.
    Barreiro E; Sznajder JI
    J Appl Physiol (1985); 2013 May; 114(9):1263-72. PubMed ID: 23305984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?
    Puig-Vilanova E; Ausin P; Martinez-Llorens J; Gea J; Barreiro E
    PLoS One; 2014; 9(7):e102296. PubMed ID: 25013984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MicroRNAs in COPD muscle dysfunction and mass loss: implications on the clinic.
    Barreiro E
    Expert Rev Respir Med; 2016 Sep; 10(9):1011-22. PubMed ID: 27348064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD.
    Puig-Vilanova E; Martínez-Llorens J; Ausin P; Roca J; Gea J; Barreiro E
    Clin Sci (Lond); 2015 Jun; 128(12):905-21. PubMed ID: 25628226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lung cancer and its epigenetics association with chronic obstructive pulmonary disease].
    Xu PW; Jin YT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):70-3. PubMed ID: 23450484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of striated muscle dysfunction during acute exacerbations of COPD.
    Gayan-Ramirez G; Decramer M
    J Appl Physiol (1985); 2013 May; 114(9):1291-9. PubMed ID: 23372146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
    Puig-Vilanova E; Aguiló R; Rodríguez-Fuster A; Martínez-Llorens J; Gea J; Barreiro E
    PLoS One; 2014; 9(11):e111514. PubMed ID: 25369292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of muscle dysfunction in COPD.
    Gea J; Agustí A; Roca J
    J Appl Physiol (1985); 2013 May; 114(9):1222-34. PubMed ID: 23519228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.
    Barreiro E; Gea J
    Chron Respir Dis; 2016 Aug; 13(3):297-311. PubMed ID: 27056059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diaphragm and skeletal muscle dysfunction in COPD].
    Caron MA; Debigaré R; Dekhuijzen PN; Maltais F
    Rev Mal Respir; 2011 Dec; 28(10):1250-64. PubMed ID: 22152934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD.
    Doucet M; Debigaré R; Joanisse DR; Côté C; Leblanc P; Grégoire J; Deslauriers J; Vaillancourt R; Maltais F
    Eur Respir J; 2004 Dec; 24(6):971-9. PubMed ID: 15572541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory and Limb Muscle Dysfunction in COPD.
    Barreiro E; Gea J
    COPD; 2015 Aug; 12(4):413-26. PubMed ID: 25438125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of skeletal muscle development and homeostasis by gene imprinting, histone acetylation and microRNA.
    Moresi V; Marroncelli N; Coletti D; Adamo S
    Biochim Biophys Acta; 2015 Mar; 1849(3):309-16. PubMed ID: 25598319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanisms of cachexia underlying muscle dysfunction in COPD.
    Remels AH; Gosker HR; Langen RC; Schols AM
    J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
    Schamberger AC; Mise N; Meiners S; Eickelberg O
    Expert Opin Drug Discov; 2014 Jun; 9(6):609-28. PubMed ID: 24850530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanisms in chronic obstructive pulmonary disease.
    Zong DD; Ouyang RY; Chen P
    Eur Rev Med Pharmacol Sci; 2015; 19(5):844-56. PubMed ID: 25807439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of the quadriceps and the diaphragm in patients with COPD.
    Caron MA; Debigaré R; Dekhuijzen PN; Maltais F
    J Appl Physiol (1985); 2009 Sep; 107(3):952-61. PubMed ID: 19359618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis-related factors in skeletal muscles of COPD patients: roles of angiopoietin-2.
    Mofarrahi M; Sigala I; Vassilokopoulos T; Harel S; Guo Y; Debigare R; Maltais F; Hussain SN
    J Appl Physiol (1985); 2013 May; 114(9):1309-18. PubMed ID: 23305976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular epigenetics: from DNA methylation to microRNAs.
    Udali S; Guarini P; Moruzzi S; Choi SW; Friso S
    Mol Aspects Med; 2013; 34(4):883-901. PubMed ID: 22981780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.